Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03602391 · ClinicalTrials.gov registry record · NA
The Senior Companion Program Plus
A NA study of Family and Alzheimer Dementia, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03602391 is a NA study of Family and Alzheimer Dementia that has completed, run by The University of Texas at Arlington. The registered enrollment target is 20 participants, below the 188-participant average among 9 other Family trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03602391, a NA study of Family and Alzheimer Dementia, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Alzheimer's disease and related dementia (ADRD) is one of the most challenging chronic health conditions in the United States and considerable disparities exist in the diagnosis and prevalence of ADRD among communities of color. Research suggests that ADRD caregiver interventions have demonstrated efficacy, however, it remains unknown whether existing ADRD caregiver interventions are useful or accessible to African American ADRD caregivers in community settings. The primary goal of the proposed project is to develop an in-home psychoeducational intervention (The Senior Companion Program Plus, or SCP Plus) that is accessible, sustainable, and affordable for African American ADRD caregivers. The SCP Plus will focus on African American ADRD caregivers who are particularly affected by poverty, discrimination, and barriers to health care services and supports. A recent pilot study has established the feasibility and utility of SCP Plus. With the assistance of 6 student research assistants over the course of the project, we will implement the SCP Plus at sites in Texas, Louisiana, and Arkansas, recruiting approximately 114 participants. The participants will be randomized with 57 caregivers receiving the SCP Plus and 57 caregivers receiving services as usual with the Senior Companion Program. A weekly, 60 minute psychoeducational module will be delivered face-to-face across 9 weeks and will focus on education about ADRD, behavior management, communication skills, and aspects of providing care that enhance meaning such as spirituality. In order to provide an accessible and cost effective intervention that is potentially sustainable, senior companions will be trained to provide the intervention in the homes of the African American ADRD caregivers. Specific Aim 1. Determine whether SCP Plus reduces level of burden and stress among African American caregivers over a 3- and 6-month period when compared to a usual care control group. Specific Aim 2. Ascertain if SCP Plus imp
Conditions Studied
Interventions
- BEHAVIORAL SCP Plus
Study Locations (1)
Texas
- The Senior Source - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03602391
The ClinicalTrials.gov registry entry for NCT03602391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 9 other Family trials with a reported enrollment target (89% lower). The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Family appearing as the primary indexed condition, and to 1 intervention - of which SCP Plus is the first listed.
NCT03602391 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03602391 about?
NCT03602391 is a clinical study titled "The Senior Companion Program Plus". Alzheimer's disease and related dementia (ADRD) is one of the most challenging chronic health conditions in the United States and considerable disparities exist in the diagnosis and prevalence of ADRD among communities of color. Research suggests that ADRD caregiver interventions have demonstrated e...
What is the current status of trial NCT03602391?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-16. Estimated completion is 2023-06-30.
What conditions does trial NCT03602391 study?
This clinical trial studies the following conditions: Family, Alzheimer Dementia.
What interventions are being tested in trial NCT03602391?
The interventions under investigation include: SCP Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT03602391?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03602391 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Family
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reporting Back Pesticide Results to Family Child Care Home Directors
RECRUITING · NA
-
Families Implementing Good Health Traditions for Life
RECRUITING · NA
-
Childhood Obesity Treatment Designed for Low Income and Hispanic Families
ACTIVE NOT RECRUITING · NA
-
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
ACTIVE NOT RECRUITING · NA
-
Families With Substance Use and Psychosis: A Pilot Study
COMPLETED · NA
-
Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.